Update in global trends and aetiology of hepatocellular carcinoma

被引:277
作者
Rawla, Prashanth [1 ]
Sunkara, Tagore [2 ]
Muralidharan, Pradhyumna [3 ]
Raj, Jeffrey Pradeep [3 ]
机构
[1] Sovah Hlth, Dept Internal Med, 320 Hosp Dr, Martinsville, VA 24112 USA
[2] Mt Sinai Hosp, Brooklyn Hosp Ctr, Div Gastroenterol & Hepatol, Clin Affiliate, New York, NY 10029 USA
[3] St Johns Med Coll, Dept Pharmacol, Bengaluru, India
来源
WSPOLCZESNA ONKOLOGIA-CONTEMPORARY ONCOLOGY | 2018年 / 22卷 / 03期
关键词
epidemiology; aetiology; hepatocellular carcinoma; HCC; risk factors; hepatitis C; HBV; incidence; prevalance; mortality;
D O I
10.5114/wo.2018.78941
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Hepatocellular carcinoma (HCC) is the most common primary cancer of the liver responsible for an increasing number of cancer-related deaths, especially in developing economies of Asia and Africa. A plethora of risk factors have been described in the literature. Some of the important ones include chronic viral hepatitis, liver cirrhosis, environmental toxins such as aflatoxin, non-alcoholic fatty liver disease, lifestyle factors like alcohol consumption, smoking, and dietary factors, metabolic diseases like diabetes mellitus and obesity, and genetic and hereditary disorders. The development of HCC is complex involving sustained inflammatory damage leading to hepatocyte necrosis, regeneration, and fibrotic deposition. It also poses multiple challenges in diagnosis and treatment despite advances in diagnostic, surgical, and other therapeutic advancements. This is a narrative review of findings of multiple studies that were retrieved from electronic databases like PubMed, MEDLINE, Embase, Google Scholar, Scopus, and Cochrane. We summarise the current knowledge regarding the epidemiology and various risk factors for the development of HCC with a brief note on various prevention strategies.
引用
收藏
页码:141 / 150
页数:10
相关论文
共 106 条
[11]   AUSTRALIA-ANTIGEN AND BIOLOGY OF HEPATITIS-B [J].
BLUMBERG, BS .
SCIENCE, 1977, 197 (4298) :17-25
[12]   Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries [J].
Bray, Freddie ;
Ferlay, Jacques ;
Soerjomataram, Isabelle ;
Siegel, Rebecca L. ;
Torre, Lindsey A. ;
Jemal, Ahmedin .
CA-A CANCER JOURNAL FOR CLINICIANS, 2018, 68 (06) :394-424
[13]  
British Liver Trust, NON REL FATT LIV DIS
[14]   Cryptogenic cirrhosis: Clinical characterization and risk factors for underlying disease [J].
Caldwell, SH ;
Oelsner, DH ;
Iezzoni, JC ;
Hespenheide, EE ;
Battle, EH ;
Driscoll, CJ .
HEPATOLOGY, 1999, 29 (03) :664-669
[15]   Hepatocellular carcinoma and non-alcoholic steatohepatitis: The state of play [J].
Charrez, Berenice ;
Qiao, Liang ;
Hebbard, Lionel .
WORLD JOURNAL OF GASTROENTEROLOGY, 2016, 22 (08) :2494-2502
[16]   Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level [J].
Chen, CJ ;
Yang, HI ;
Su, J ;
Jen, CL ;
You, SL ;
Lu, SN ;
Huang, GT ;
Iloeje, UH .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2006, 295 (01) :65-73
[17]   Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls [J].
Chen, SY ;
Wang, LY ;
Lunn, RM ;
Tsai, WY ;
Lee, PH ;
Lee, CS ;
Ahsan, H ;
Zhang, YJ ;
Chen, CJ ;
Santella, RM .
INTERNATIONAL JOURNAL OF CANCER, 2002, 99 (01) :14-21
[18]   Cancer burden from arsenic in drinking water in Bangladesh [J].
Chen, Y ;
Ahsan, H .
AMERICAN JOURNAL OF PUBLIC HEALTH, 2004, 94 (05) :741-744
[19]   Polymorphisms in the epidermal growth factor receptor gene and the risk of primary lung cancer:: a case-control study [J].
Choi, Jin Eun ;
Park, Sun Ha ;
Kim, Kyung Mee ;
Lee, Won Kee ;
Kam, Sin ;
Cha, Sung Ick ;
Kim, Chang Ho ;
Kang, Young Mo ;
Kim, Young-Chul ;
Han, Sung Beom ;
Jung, Tae Hoon ;
Park, Jae Yong .
BMC CANCER, 2007, 7 (1)
[20]   Comparison of hepatocellular carcinoma in Eastern versus Western populations [J].
Choo, Su Pin ;
Tan, Wan Ling ;
Goh, Brian K. P. ;
Tai, Wai Meng ;
Zhu, Andrew X. .
CANCER, 2016, 122 (22) :3430-3446